12 results · 28ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

DESARA BLUE OV, DESARA BLUE SS

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

HISTOACRYL FLEXIBLE PACK 5

FDA Adverse Event
Malfunction ·B.BRAUN SURGICAL SA·Product code MPN·December 3, 2019

HEMOSIL VON WILLEBRAND ACTIVITY

FDA 510(k)
FDA Class 2 ·Hematology

ABREU, MODEL 700

FDA 510(k)
FDA Class 2 ·General Hospital

MECHANICAL (MANUAL) WHEELCHAIR

FDA Adverse Event
Malfunction ·INVACARE TAYLOR STREET·Product code IOR·October 3, 2014

SECURE II MED/SURG BED

FDA Adverse Event
Malfunction ·STRYKER MEDICAL·Product code FNL·May 31, 2011

6800

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS, INC.·Product code JAA·September 3, 2008

SYNCHRO2-14 SUPPORT STRAIGHT 215CM

FDA Adverse Event
Malfunction ·STRYKER NEUROVASCULAR-UTAH-SALT LAKE CITY·Product code DQX·December 14, 2023

HISTOACRYL FLEXIBLE PACK 5

FDA Adverse Event
Malfunction ·B. BRAUN SURGICAL SA·Product code MPN·February 11, 2020

HISTOACRYL TRANSLUCENT 10 AMP OF 0.5 ML

FDA Adverse Event
Injury ·B. BRAUN SURGICAL SA·Product code MPN·February 26, 2020

C-Series High Energy Linear Accelerator - Models: Novalis Tx, Trilogy, Trilogy Tx, Clinac iX, Clinac 2100 C/D, Clinac 2300C/D, Clinac 21EX, Clinac 23EX with versions 7, 8, 9 and 6 MV configuration and maximum dose rate of at least 6000 MU/min only. Varian High Energy Linear Accelerator is intended to provide sterotactic radiosurgery and precision radio-therapy for lesions, tumors and conditions anywhere in the body when radiation treatment is indicated.

FDA Enforcement
Class II ·Terminated·Varian Medical Systems, Inc.·September 24, 2014

Varian High Energy Clinacs, High Energy Accelerator, Radiation Treatment System, Model Numbers: H14, H27, H29, HCX. Product Usage: The Varian High Energy Accelerator is intended to provide stereotactic radiosurgery and precision radiotherapy for lesions, tumors and conditions anywhere in the body when radiation treatment is indicated.

FDA Enforcement
Class II ·Terminated·Varian Medical Systems, Inc. Oncology Systems·May 22, 2013